Cardiovascular disease (CVD) is a major player in health-related deaths in the United States. In many cases, comorbidities of cardiac stress, such as diabetes or hypertension cause persistent changes in the nutrients and hormones circulating the body. In addition to the long-term physical load on the heart, the heart cannot maintain function efficiently. Long-term cardiac stress can arise because of CVD and changes in cardiac metabolism are often the first observed adaptations to cardiac stress. This ties in with the observation that many of the predisposing factors for cardiac stress are metabolic disorders themselves, such as obesity, diabetes and high cholesterol.
During pressure overload to the heart, there is increased demand for ATP (adenosine triphosphate, the energy currency for cells) production by cardiomyocytes. In order to try and fulfil this demand, there is an initial increase in fatty acid oxidation, followed by increased aerobic glycolysis and a corresponding increase in glycolytic gene expression. However, as oxygen becomes scarce, anaerobic glycolysis kicks in, and this leads to accumulation of lactic acid. Bad news for the heart.
The cardiac stress response has a varied molecular signature, depending on the stress and on the genetic background of the animal. This makes identifying key regulators of the stress response very difficult, as we need to try and distinguish them from the background variation and ‘noise’ that we see. If we could identify factors that play a part in coordinating the cardiac stress response, maybe this would provide a way in which to diagnose early stage cardiac stress, before it becomes apparent clinically and at a point when the patient will be more responsive to treatment.
Professor Reineke’s group want to solve several questions, including what cellular proteins sense stress signals and what proteins are responsible for coordinating the subsequent changes in the transcriptional machinery.
From the heart
Ultimately, heart failure results from changes that occur in the heart after the onset of stress, such as alterations in cellular signalling cascades and gene expression profiles. Three of the main pathways important for the heart to maintain normal functions under stress conditions are those relating to cardiac metabolism, growth and structure. In many cases, changes in the metabolic pathways result from a gene profile that resembles the one seen during foetal development, the ‘foetal gene profile’. This alteration in gene expression is controlled by transcription factors, and the shift away from the adult cardiac gene expression profile is associated with pressure overload, aging and inadequate blood supply. So far, research has identified changes in transcription of only a small set of markers for cardiac stress. However, we don’t know much about the transcriptional regulators for these genes, and even less about possible upstream signals.
Of mice and men
The steroid receptor (SRC) family of proteins has been well studied for their role in co-activating a number of transcription factors in response to cellular signals. One family member of particular interest to Professor Reineke was steroid receptor-2 (SRC-2). Its role in controlling enzymes of fatty acids and glucose metabolism have already been reported. SRC-2 is a transcription activator; it acts as a large scaffold that allows other proteins to dock, interact or be modified. Therefore, it is perfectly placed to be a signal coordinator during cardiac stress.
Furthermore, previous studies investigating human heart failure had identified SRC-2 as one of only 107 genes that showed altered expression in more than one dataset. Consequently, Reineke and colleagues set about investigating a mouse model that lacked SRC-2, to see what effect it had on the ability of the mouse to cope with cardiac stress. Without SRC-2, the mice could not mount a proper response to left ventricular pressure overload, a phenomenon often seen in persistent cardiac stress. There was a shift in gene expression towards the so-called foetal gene signature in the unstressed hearts of the mice, suggesting involvement of SRC-2 with the adult metabolic gene profile. The study also found that that SRC-2 was important for cardiomyocyte function, as it could control several cardiac transcription factors, including one that is important for maintaining adult cardiomyocyte metabolism. Future projects will continue to investigate other key regulators that may be involved in the cardiac stress response.
Despite these changes, the ability of the heart to function correctly was not impeded. Maybe the hearts of these mice are predisposed to cardiac decline with increasing stress, but it is not a change we see straight away. Meanwhile, this shift towards a foetal gene profile is enough to meet the steady-state energy demands of the heart.
Professor Reineke’s current work focuses on the impact that early metabolic signals may have on the downstream stress response. She hypothesises that the abrogated growth of the walls of the heart, observed in the mice lacking SRC-2, could be a direct result of the metabolic profile of the heart being altered, even before cardiac changes are visible. Ongoing research also investigates the differences that timing makes. Are there different results depending on when the normal stress response is disrupted? And what molecules are responsible for regulation and control of these processes?
An early warning system
Imagine if you will, a clinical setting in which patients suspected of having high blood pressure with the potential to lead to more long-term problems, could be treated much earlier. As a result of the research done by the group at the Houston Methodist Research Institute and the findings from their SRC-2 mice, it may become possible to screen patients for the tell-tale early markers of cardiac metabolic changes, and to then to prescribe a personalised transcriptional therapy, saving the patient’s cardiac gene profile from reaching the point of no return, and therefore from developing full blown CVD.
Our current work regarding SRC-2 is focused on determining what stress signals regulate its activity and expression, as well as how these signals dictate what pathways SRC-2 regulates. We anticipate that these studies will uncover information directly related to SRC-2 control and signalling and also how the multiple signals that a heart receives during stress are interrelated.
Given that the effects of SRC-2 have been linked to other metabolic pathways, such as glucose metabolism, did you see any other metabolic changes in your mice lacking SRC-2, such as weight gain or any diabetes-like symptoms?
Whole body knockouts of SRC-2 have defects in several metabolic tissues that are mainly apparent under increased stress, such as exercise, effecting their light/dark cycle, or starvation. Because these will all lead to changes in systemic hormones and other signals, we have moved our attention to mice specifically lacking SRC-2 in the cardiomyocytes. In these mice, we do not see development of long-term metabolic defects, but can systematically study the specific effects of altered metabolism in the cardiomyocyte driven by SRC-2 and how systemic metabolic changes, such as those observed during diabetes, effect cardiomyocyte metabolism.
SRC-2 represents just one molecule which is involved in cardiac stress, can you comment on what other molecules you would like to target in future?
We are interested in identifying key regulators that play roles in multiple pathways that are activated during cardiac stress, but that have dual functional roles in the cell. We believe that this positions them well to act as coordinators of a stress response. For example, we are currently investigating the metabolic sensor AMP-activated kinase (AMPK) during cardiac stress. AMPK is activated under low energy states and has roles in controlling metabolic flux, protein translation as is needed for stress-induced cardiac growth, and transcription regulation. Therefore, it could potentially act to coordinate metabolic changes with growth changes.
How do you see your research being translated practically into future diagnostic tools and therapies for patients?
Our research has the potential to uncover novel targets that are important in maintaining cardiac function that may be targeted during cardiac stress, as well as suggest possible early pathways that change and could send signals into the blood stream that would allow early detection. During cardiac stress, there are many changes, but some are adaptive and aid the heart, while others become maladaptive. Understanding what these are and when they occur is crucial to really understanding and treating the molecular mechanisms underlying heart failure.
You have achieved a great deal in your career so far, have you got any advice for women in science (especially early career researchers)?
Believe in yourself, be true to yourself, and always work hard for what you want. The path to an independent researcher has unique side roads for everyone and the “traditional” path almost doesn’t exist anymore. If you can just focus on yourself and avoid the negative competitiveness that so often occurs among peers in science, you will know that you worked as hard as you could for each career step or accomplishment, win lose or draw. Life always has many changes. Be it moving, or marriage, or kids to name a few, let these be part of your life. Figure out the balance that makes you happy and just keep moving forward. Academic science requires a lot of individual determination and drive and often the future remains very uncertain, but that’s part of what drives us all to push the boundaries of research as well.
Professor Reineke’s independent research career is focused on identifying and understanding the molecular mechanisms coordinating the cardiac stress response, with a specific focus on understanding how very early changes in cardiac metabolism at the onset of stress relay signals to other adaptive pathways including hypertrophy.
National Heart, Lung and Blood Institute (NHLBI)
- Dr Dale Hamilton
- Dr Mark Entman
- Dr George Taffet
- Dr Heinrich Taegtmeyer
- Dr John Cooke
Professor Erin Reineke completed her graduate studies at Case Western Reserve University, Cleveland, and postdoctoral training at Baylor College of Medicine, Houston, Texas. Her postdoctoral studies investigated transcriptional regulation of skeletal muscle metabolism by a class of transcription coactivators: the steroid receptor coactivators (SRCs), and led to her current interest in metabolic control of cardiac muscle during cardiac stress events.
Professor Erin Reineke
Assistant Professor of Bioenergetics
Institute for Academic Medicine
Center for Bioenergetics
Houston Methodist Research Institute
Weill Cornell Medical College
6670 Bertner Ave
Houston, TX 77030
T: +1 7133 63 9933